2025-08-29 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc (TDOC) based on the provided data, presented in a report format.

## Teladoc Health Inc (TDOC) Stock Analysis

**Company Overview:** Teladoc Health Inc. is a telehealth company that provides virtual healthcare services.

### 1. Performance vs. S&P 500 (VOO)

*   **TDOC Cumulative Return:** -63.24%
*   **VOO Cumulative Return:** 103.67%
*   **Relative Deviation:** -272.4
*   **Relative Deviation (Percentile):** 0.3
*   **Analysis:** TDOC has significantly underperformed the S&P 500. The relative deviation indicates substantial underperformance compared to the benchmark, placing it near the bottom of its historical range relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2015-2017  | 76.0%   | 60.6% | 50.0%   | -0.0  | 6.2    |
| 2016-2018  | 128.0%  | 59.3% | 110.0%  | -0.0  | 8.8    |
| 2017-2019  | 176.0%  | 59.3% | 147.0%  | 0.4   | 14.8   |
| 2018-2020  | 237.0%  | 64.0% | 217.0%  | 0.1   | 35.3   |
| 2019-2021  | -83.0%  | 64.0% | -132.0% | 0.1   | 16.2   |
| 2020-2022  | -295.0% | 81.3% | -297.0% | 0.0   | 4.2    |
| 2021-2023  | -488.0% | 81.3% | -506.0% | -0.6  | 3.8    |
| 2022-2024  | -111.0% | 81.3% | -137.0% | -0.8  | 1.6    |
| 2023-2025  | -34.0%  | 75.5% | -88.0%  | -0.8  | 1.4    |

*   **Analysis:**  The table highlights a significant decline in performance in recent years. CAGR is negative, MDD is high, and Alpha is strongly negative. Beta fluctuates, indicating varying degrees of correlation with the market. The capitalization also shows a sharp decline, suggesting shrinking market value.

### 2. Recent Stock Price Movement

*   **Current Price:** $7.89
*   **Previous Close:** $7.74
*   **Change:** 1.94%
*   **5-Day Moving Average:** 7.758
*   **20-Day Moving Average:** 7.2855
*   **60-Day Moving Average:** 7.6653

*   **Analysis:**  The stock is currently trading above its 5-day, 20-day, and 60-day moving averages, suggesting a short-term bullish trend. The recent price change of 1.94% indicates a notable upward movement.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.3266 (Low Risk)
*   **RSI:** 69.46 (Approaching Overbought)
*   **PPO:** 1.32
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (1 shares - Safe - MRI:0.32)
*   **Recent Relative Deviation Change:** 0.1 (Positive - Short-term Increase)
*   **Expected Return:** -11021.1%

*   **Analysis:**  The MRI indicates low market risk. The RSI is approaching overbought levels, suggesting the recent upward movement may be unsustainable in the short term. The positive change in relative deviation signals short-term upward momentum. The Hybrid Signal suggests a buying opportunity. However, the extremely negative expected return raises serious concerns about long-term investment prospects.

### 4. Recent News & Significant Events

*   **Recent News:**  TDOC has been in the news due to business developments, regulatory changes, market events, analyst discussions, and stock volatility.
*   **Analysis:**  The news suggests the company is undergoing significant changes and experiencing volatility, requiring investors to stay informed.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-07-30 | -0.19 | 0.63 B$   |
| 2025-05-01 | -0.53 | 0.63 B$   |
| 2024-10-31 | -0.19 | 0.64 B$   |
| 2024-08-01 | -4.92 | 0.64 B$   |
| 2025-07-30 | -4.92 | 0.64 B$   |

*   **Analysis:** The EPS (Earnings Per Share) is negative in all reported quarters, indicating unprofitability. Revenue is relatively stable around $0.63-$0.64 billion.  The large negative EPS figures (-4.92) in some quarters are concerning and require further investigation.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-06-30   | $0.63B  | 69.85%        |
| 2025-03-31   | $0.63B  | 68.73%        |
| 2024-12-31   | $0.64B  | 70.50%        |
| 2024-09-30   | $0.64B  | 71.94%        |
| 2024-06-30   | $0.64B  | 70.73%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE       |
|--------------|---------|-----------|
| 2025-06-30   | $1.42B  | -2.30%    |
| 2025-03-31   | $1.43B  | -6.52%    |
| 2024-12-31   | $1.49B  | -3.25%    |
| 2024-09-30   | $1.51B  | -2.21%    |
| 2024-06-30   | $1.50B  | -55.77%   |

*   **Analysis:** Revenue is consistent, and the profit margin is high, which is a positive sign. However, the negative ROE (Return on Equity) indicates the company is not generating profits relative to its equity.  Equity is also decreasing over time.

### 7. Overall Analysis and Conclusion

Based on the provided data, Teladoc Health Inc. (TDOC) presents a mixed picture.

*   **Strengths:** High profit margins on revenue. Recent short-term positive price movement. Low Market Risk Indicator.
*   **Weaknesses:**  Significant underperformance compared to the S&P 500. Negative and declining CAGR. Negative EPS and ROE, indicating persistent unprofitability. Declining Equity. Extremely negative expected return. High MDD suggesting high volatility.
*   **Concerns:**  The significant underperformance compared to the S&P 500, negative earnings, and extremely negative expected return are major red flags.
*   **Recommendation:**  Given the company's poor financial performance and the substantial risks involved, a cautious approach is warranted. Further investigation is needed to understand the reasons behind the negative earnings and the company's plans to address these issues. Investors should carefully consider their risk tolerance before investing in TDOC.
